Healthcare provider profile · identity verified

Mridula Menon, MD

Internal Medicine · LINCOLN, RI · NPI 1427045301

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	749	195
Levothyroxine Sodium	Levothyroxine Sodium	604	139
Amlodipine Besylate	Amlodipine Besylate	554	142
Lisinopril	Lisinopril	432	110
Losartan Potassium	Losartan Potassium	378	88
Omeprazole	Omeprazole	354	88
Hydrochlorothiazide	Hydrochlorothiazide	233	70
Trazodone Hcl	Trazodone Hcl	229	53
Gabapentin	Gabapentin	198	41
Simvastatin	Simvastatin	191	51
Rosuvastatin Calcium	Rosuvastatin Calcium	181	49
Sertraline Hcl	Sertraline Hcl	175	48
Metoprolol Succinate	Metoprolol Succinate	174	43
Atenolol	Atenolol	157	40
Alprazolam	Alprazolam	156	30
Escitalopram Oxalate	Escitalopram Oxalate	156	31
Lorazepam	Lorazepam	152	31
Pantoprazole Sodium	Pantoprazole Sodium	149	40
Albuterol Sulfate Hfa	Albuterol Sulfate	123	43
Famotidine	Famotidine	123	37
Eliquis	Apixaban	122	26
Metoprolol Tartrate	Metoprolol Tartrate	122	28
Jardiance	Empagliflozin	111	15
Fluticasone Propionate	Fluticasone Propionate	107	50
Pravastatin Sodium	Pravastatin Sodium	104	27
Montelukast Sodium	Montelukast Sodium	102	23
Tramadol Hcl	Tramadol Hcl	100	19
Fluoxetine Hcl	Fluoxetine Hcl	96	19
Alendronate Sodium	Alendronate Sodium	89	21
Duloxetine Hcl	Duloxetine Hcl	88	19
Citalopram Hbr	Citalopram Hydrobromide	84	21
Metformin Hcl	Metformin Hcl	84	27
Furosemide	Furosemide	83	27
Glipizide	Glipizide	81	14
Metformin Hcl Er	Metformin Hcl	80	27
Ozempic	Semaglutide	79	14
Bupropion Xl	Bupropion Hcl	78	20
Clonazepam	Clonazepam	77	suppressed
Potassium Chloride	Potassium Chloride	71	17
Venlafaxine Hcl Er	Venlafaxine Hcl	70	14
Valsartan	Valsartan	66	16
Meclizine Hcl	Meclizine Hcl	65	24
Ibuprofen	Ibuprofen	62	22
Allopurinol	Allopurinol	60	12
Valacyclovir	Valacyclovir Hcl	59	20
Lovastatin	Lovastatin	57	16
Buspirone Hcl	Buspirone Hcl	51	suppressed
Mirtazapine	Mirtazapine	51	15
Ropinirole Hcl	Ropinirole Hcl	51	suppressed
Breo Ellipta	Fluticasone/Vilanterol	50	suppressed
Spironolactone	Spironolactone	50	14
Tamsulosin Hcl	Tamsulosin Hcl	50	11
Zolpidem Tartrate	Zolpidem Tartrate	50	17
Meloxicam	Meloxicam	47	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	14
Pregabalin	Pregabalin	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	11
Synthroid	Levothyroxine Sodium	41	12
Celecoxib	Celecoxib	40	suppressed
Trulicity	Dulaglutide	40	suppressed
Propranolol Hcl	Propranolol Hcl	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	12
Prednisone	Prednisone	32	27
Klor-Con M20	Potassium Chloride	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	18
Nystatin	Nystatin	30	11
Donepezil Hcl	Donepezil Hcl	29	suppressed
Glimepiride	Glimepiride	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Diazepam	Diazepam	28	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Ketoconazole	Ketoconazole	24	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Baclofen	Baclofen	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Carvedilol	Carvedilol	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	15
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Glipizide Er	Glipizide	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Naproxen	Naproxen	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Topiramate	Topiramate	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Temazepam	Temazepam	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error